Investing Profile

Matthew Foy

Photo of Matthew Foy, Partner at SR One
University of Oxford Network
96 CONNECTIONS
London Business School Network
66 CONNECTIONS
UCL Network
26 CONNECTIONS
cb
SR One Partner
3
CompanyStageDateRound SizeTotal Raised
Fore Biotherapeutics
Series DAug 2023$75M
$130M
Co-investors: Michal Silverberg (Novartis Venture Fund), Roberto De Ponti (3B Future Health Ventures (Helsinn Investment Fund)), Chandra Leo (Hbm Partners), Ran Nussbaum (Pontifax Venture Capital)
Akamis Bio
Series CMay 2015$39M
Series BJul 2012$34M
$110M
Co-investors: Maina Bhaman (Soffinova Partners), Robert Nelsen (ARCH Venture Partners)
Fund raising The Grange Festival2015 - Present
Founder OneStart2012 - Present
Partner SROne2011 - Present
Fund Raising The Royal Ballet School2011 - Present
Consultant Longbow Capital LLP2010 - 2011
Vice President - M&A Banker / Private Equity Greenhill & Co.2002 - 2010
UCL Drug Discovery
London Business School Entrepreneurship & Strategy
University of Oxford BSc & MSc Biological Sciences - Cell and Molecular Biology